FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945550327> ?p ?o ?g. }

• W2945550327 endingPage "29" @default.
• W2945550327 startingPage "13" @default.
• W2945550327 abstract "The oncogenic Epstein–Barr virus (EBV) evades the immune system through limiting the expression of its highly antigenic and essential genome maintenance protein, EBNA1, to the minimal level to ensure viral genome replication, thereby also minimizing the production of EBNA1-derived antigenic peptides. This regulation is based on inhibition of translation of the virally-encoded EBNA1 mRNA, and involves the interaction of host protein nucleolin (NCL) with G-quadruplex (G4) structures that form in the glycine–alanine repeat (GAr)-encoding sequence of the EBNA1 mRNA. Ligands that bind to these G4-RNA can prevent their interaction with NCL, leading to disinhibition of EBNA1 expression and antigen presentation, thereby interfering with the immune evasion of EBNA1 and therefore of EBV (M.J. Lista et al., Nature Commun., 2017, 8, 16043). In this work, we synthesized and studied a series of 20 cationic bis(acylhydrazone) derivatives designed as G4 ligands. The in vitro evaluation showed that most derivatives based on central pyridine (Py), naphthyridine (Naph) or phenanthroline (Phen) units were efficient G4 binders, in contrast to their pyrimidine (Pym) counterparts, which were poor G4 binders due to a significantly different molecular geometry. The influence of lateral heterocyclic units (N-substituted pyridinium or quinolinium residues) on G4-binding properties was also investigated. Two novel compounds, namely PyDH2 and PhenDH2, used at a 5 μM concentration, were able to significantly enhance EBNA1 expression in H1299 cells in a GAr-dependent manner, while being significantly less toxic than the prototype drug PhenDC3 (GI50 > 50 μM). Antigen presentation, RNA pull-down and proximity ligation assays confirmed that the effect of both drugs was related to the disruption of NCL–EBNA1 mRNA interaction and the subsequent promotion of GAr-restricted antigen presentation. Our work provides a novel modular scaffold for the development of G-quadruplex-targeting drugs acting through interference with G4–protein interaction." @default.
• W2945550327 created "2019-05-29" @default.
• W2945550327 creator A5011476646 @default.
• W2945550327 creator A5013133434 @default.
• W2945550327 creator A5020003482 @default.
• W2945550327 creator A5029672015 @default.
• W2945550327 creator A5032046128 @default.
• W2945550327 creator A5033219140 @default.
• W2945550327 creator A5046018921 @default.
• W2945550327 creator A5046276408 @default.
• W2945550327 creator A5046831416 @default.
• W2945550327 creator A5062059107 @default.
• W2945550327 creator A5067544327 @default.
• W2945550327 creator A5071716642 @default.
• W2945550327 creator A5075694197 @default.
• W2945550327 creator A5076596128 @default.
• W2945550327 creator A5085930450 @default.
• W2945550327 date "2019-09-01" @default.
• W2945550327 modified "2023-10-16" @default.
• W2945550327 title "Novel cationic bis(acylhydrazones) as modulators of Epstein–Barr virus immune evasion acting through disruption of interaction between nucleolin and G-quadruplexes of EBNA1 mRNA" @default.
• W2945550327 cites W1589882707 @default.
• W2945550327 cites W1914649288 @default.
• W2945550327 cites W1941998121 @default.
• W2945550327 cites W1969360633 @default.
• W2945550327 cites W1976211173 @default.
• W2945550327 cites W1981783595 @default.
• W2945550327 cites W1993817916 @default.
• W2945550327 cites W2003076573 @default.
• W2945550327 cites W2005281689 @default.
• W2945550327 cites W2013566223 @default.
• W2945550327 cites W2018104916 @default.
• W2945550327 cites W2026370504 @default.
• W2945550327 cites W2028673140 @default.
• W2945550327 cites W2043509228 @default.
• W2945550327 cites W2047184081 @default.
• W2945550327 cites W2060001883 @default.
• W2945550327 cites W2060773732 @default.
• W2945550327 cites W2062008740 @default.
• W2945550327 cites W2063334178 @default.
• W2945550327 cites W2070992723 @default.
• W2945550327 cites W2075316517 @default.
• W2945550327 cites W2088038191 @default.
• W2945550327 cites W2091300209 @default.
• W2945550327 cites W2092430017 @default.
• W2945550327 cites W2104126948 @default.
• W2945550327 cites W2107255195 @default.
• W2945550327 cites W2115187133 @default.
• W2945550327 cites W2135193909 @default.
• W2945550327 cites W2143175629 @default.
• W2945550327 cites W2143920992 @default.
• W2945550327 cites W2153013045 @default.
• W2945550327 cites W2166630132 @default.
• W2945550327 cites W2169469451 @default.
• W2945550327 cites W2204831895 @default.
• W2945550327 cites W2318569979 @default.
• W2945550327 cites W2323449394 @default.
• W2945550327 cites W2396930286 @default.
• W2945550327 cites W2593436234 @default.
• W2945550327 cites W2610354867 @default.
• W2945550327 cites W2619324489 @default.
• W2945550327 cites W2725779950 @default.
• W2945550327 cites W2751191719 @default.
• W2945550327 cites W2790747858 @default.
• W2945550327 cites W2792386469 @default.
• W2945550327 cites W2795709906 @default.
• W2945550327 cites W2805804454 @default.
• W2945550327 cites W2847442958 @default.
• W2945550327 cites W2889646874 @default.
• W2945550327 cites W2902921100 @default.
• W2945550327 doi "https://doi.org/10.1016/j.ejmech.2019.05.042" @default.
• W2945550327 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31173968" @default.
• W2945550327 hasPublicationYear "2019" @default.
• W2945550327 type Work @default.
• W2945550327 sameAs 2945550327 @default.
• W2945550327 citedByCount "30" @default.
• W2945550327 countsByYear W29455503272019 @default.
• W2945550327 countsByYear W29455503272020 @default.
• W2945550327 countsByYear W29455503272021 @default.
• W2945550327 countsByYear W29455503272022 @default.
• W2945550327 countsByYear W29455503272023 @default.
• W2945550327 crossrefType "journal-article" @default.
• W2945550327 hasAuthorship W2945550327A5011476646 @default.
• W2945550327 hasAuthorship W2945550327A5013133434 @default.
• W2945550327 hasAuthorship W2945550327A5020003482 @default.
• W2945550327 hasAuthorship W2945550327A5029672015 @default.
• W2945550327 hasAuthorship W2945550327A5032046128 @default.
• W2945550327 hasAuthorship W2945550327A5033219140 @default.
• W2945550327 hasAuthorship W2945550327A5046018921 @default.
• W2945550327 hasAuthorship W2945550327A5046276408 @default.
• W2945550327 hasAuthorship W2945550327A5046831416 @default.
• W2945550327 hasAuthorship W2945550327A5062059107 @default.
• W2945550327 hasAuthorship W2945550327A5067544327 @default.
• W2945550327 hasAuthorship W2945550327A5071716642 @default.
• W2945550327 hasAuthorship W2945550327A5075694197 @default.
• W2945550327 hasAuthorship W2945550327A5076596128 @default.
• W2945550327 hasAuthorship W2945550327A5085930450 @default.
• W2945550327 hasBestOaLocation W29455503271 @default.
• W2945550327 hasConcept C104317684 @default.

• next